항균 카테터 시장 규모, 점유율, 동향 분석 보고서 : 제품 종류별, 기술별, 재료별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Antimicrobial Catheters Market Summary

The global antimicrobial catheters market size was estimated at USD 1.43 billion in 2025 and is projected to reach USD 2.86 billion by 2033, growing at a CAGR of 9.0% from 2026 to 2033. The growth of this market is primarily driven by the increasing incidence of hospital-acquired infections, particularly catheter-associated urinary tract infections, which pose significant clinical and economic burdens on healthcare systems worldwide.

Rising awareness among healthcare providers and patients about infection prevention and the benefits of antimicrobial catheters is further fueling market adoption. In addition, ongoing technological advancements, such as catheters coated with silver alloy, antibiotics, or novel antimicrobial polymers, are enhancing catheter efficacy and reducing infection rates. The expanding geriatric population, who are more prone to urinary complications and prolonged catheter use, also contributes to higher demand.

Ventilator-associated events (VAE), catheter-associated urinary tract infections (CAUTIs), and central line-associated bloodstream infections (CLABSI) are key healthcare-associated infections that significantly drive the growth of the antimicrobial catheters market. These infections are common complications in hospitalized and critically ill patients, leading to increased morbidity, extended hospital stays, and higher healthcare costs. Antimicrobial catheters, designed to resist microbial colonization and biofilm formation, reduce the incidence of these infections. The rising prevalence of VAEs, CAUTIs, and CLABSIs has created strong demand for catheter solutions with advanced antimicrobial technologies, as hospitals and healthcare providers prioritize patient safety, infection prevention, and regulatory compliance. Accordingly, the need to minimize these infections fuels market adoption and innovation in antimicrobial catheter products.

Global Antimicrobial Catheters Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the antimicrobial catheters market report on the basis of product type, technology, material, end use, and region:

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)
• Urological Catheters
• Vascular Access Catheters
• Specialty and Surgical Catheters
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Silver-Based Technology
• Antibiotic-Impregnated
• Organic/Polymer-Based (Non-Metal/Non-Antibiotic)
• Combination Technologies
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Silicone
• Polyurethane (PU)
• Latex
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Long-Term Care Facilities (LTCs)
• Home Care
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product Type
  • 1.2.2. Technology
  • 1.2.3. Material
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Antimicrobial Catheters Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising incidence of Healthcare-associated Infections (HAIs)
    • 3.2.1.2. Increasing surgical procedures and hospital admissions
    • 3.2.1.3. Growing aging population with higher catheterization needs
    • 3.2.1.4. Advancements in antimicrobial coating technologies
    • 3.2.1.5. Increasing awareness about catheter-associated infection risks
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Higher cost of antimicrobial catheters compared to standard catheters
    • 3.2.2.2. Strict regulatory approval processes
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Expansion of home healthcare and ambulatory care settings
    • 3.2.3.2. Growing demand in emerging markets
    • 3.2.3.3. Development of non-antibiotic antimicrobial technologies
    • 3.2.3.4. Increasing investments in healthcare infrastructure globally
    • 3.2.3.5. Rising focus on reducing hospital stay duration and readmissions
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Pricing pressure from healthcare providers and procurement bodies
    • 3.2.4.2. Need for continuous innovation to address resistant pathogens
• 3.3. Antimicrobial Catheters Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Antimicrobial Catheters Market: Product Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Antimicrobial Catheters Market: Product Type Movement Analysis
• 4.3. Antimicrobial Catheters Market by Product Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Urological Catheters
  • 4.5.1. Urological Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Vascular Access Catheters
  • 4.6.1. Vascular Access Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Specialty and Surgical Catheters
  • 4.7.1. Specialty and Surgical Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Antimicrobial Catheters Market: Technology Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Antimicrobial Catheters Market: Technology Movement Analysis
• 5.3. Antimicrobial Catheters Market by Technology Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Silver-Based Technology
  • 5.5.1. Silver-Based Technology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Antibiotic-Impregnated
  • 5.6.1. Antibiotic-Impregnated Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Organic/Polymer-Based (Non-Metal/Non-Antibiotic)
  • 5.7.1. Organic/Polymer-Based (Non-Metal/Non-Antibiotic) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Combination Technologies
  • 5.8.1. Combination Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Antimicrobial Catheters Market: Material Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Antimicrobial Catheters Market: Material Movement Analysis
• 6.3. Antimicrobial Catheters Market by Material Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Silicone
  • 6.5.1. Silicone Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Polyurethane (PU)
  • 6.6.1. Polyurethane (PU) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Latex
  • 6.7.1. Latex Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Antimicrobial Catheters Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Antimicrobial Catheters Market: End Use Movement Analysis
• 7.3. Antimicrobial Catheters Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. Hospitals
  • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Long-Term Care Facilities (LTCs)
  • 7.6.1. Long-Term Care Facilities (LTCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Home Care
  • 7.7.1. Home Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Ambulatory Surgery Centers (ASCs)
  • 7.8.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.9. Others
  • 7.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Antimicrobial Catheters Market: Regional Estimates & Trend Analysis, by Product Type, by Technology, by Materia, and by End Use

• 8.1. Regional Dashboard
• 8.2. Regional Antimicrobial Catheters Market Movement Analysis & Market Share, 2025 & 2033
• 8.3. Antimicrobial Catheters Market: Regional Estimates & Trend Analysis
• 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 8.5. North America
  • 8.5.1. North America Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. U.S. Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Canada Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. Mexico Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Europe
  • 8.5.6. Europe Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. UK
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. UK Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Germany
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Reimbursement scenario
    • 8.5.8.5. Germany Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. France
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Reimbursement scenario
    • 8.5.9.5. France Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.10. Italy
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Reimbursement scenario
    • 8.5.10.5. Italy Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.11. Spain
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Reimbursement scenario
    • 8.5.11.5. Spain Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.12. Denmark
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competitive Scenario
    • 8.5.12.3. Regulatory Framework
    • 8.5.12.4. Reimbursement scenario
    • 8.5.12.5. Denmark Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.13. Sweden
    • 8.5.13.1. Key Country Dynamics
    • 8.5.13.2. Competitive Scenario
    • 8.5.13.3. Regulatory Framework
    • 8.5.13.4. Reimbursement scenario
    • 8.5.13.5. Sweden Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.14. Norway
    • 8.5.14.1. Key Country Dynamics
    • 8.5.14.2. Competitive Scenario
    • 8.5.14.3. Regulatory Framework
    • 8.5.14.4. Reimbursement scenario
    • 8.5.14.5. Norway Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Japan Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. China Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. India Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement scenario
    • 8.6.5.5. South Korea Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Reimbursement scenario
    • 8.6.6.5. Australia Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Reimbursement scenario
    • 8.6.7.5. Thailand Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Brazil Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Argentina Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Reimbursement scenario
    • 8.8.2.5. South Africa Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. Saudi Arabia Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. UAE Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Reimbursement scenario
    • 8.8.5.5. Kuwait Antimicrobial Catheters Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Shre Analysis, 2025
• 9.3. Key Company Profiles
  • 9.3.1. B. Braun SE
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. Teleflex Incorporated
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. SilvoGuard
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. BD
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. MEDLINE
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. ConvaTec Group PLC
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Silq Technologies
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. AvantGuard (Halomine Inc.)
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Medtronic
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Cook
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Integra LifeSciences Corporation
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. Vygon
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives
  • 9.3.13. Camstent
    • 9.3.13.1. Company overview
    • 9.3.13.2. Financial performance
    • 9.3.13.3. Product benchmarking
    • 9.3.13.4. Strategic initiatives